Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Nystatin (Fungicidin): Polyene Antifungal Agent for Candi...

    2026-01-09

    Nystatin (Fungicidin): Polyene Antifungal Agent for Candida Research

    Executive Summary: Nystatin (Fungicidin) is a polyene antifungal antibiotic that disrupts fungal membranes by binding ergosterol, leading to cell death (APExBIO). It demonstrates potent inhibitory effects against multiple Candida species, including C. albicans, with MIC90 values around 4 mg/L under standard conditions (DOI). Liposomal formulations provide protection against Aspergillus infections in neutropenic mouse models at doses as low as 2 mg/kg/day (DOI). Nystatin does not inhibit clathrin-mediated viral entry in aquatic reovirus models (Wang et al. 2018). Proper handling and storage are critical to maintain compound integrity and reproducibility in research workflows (APExBIO).

    Biological Rationale

    Nystatin (Fungicidin) is a polyene antifungal agent produced by Streptomyces noursei (APExBIO). It is primarily used to study fungal cell membrane biology and antifungal susceptibility. Nystatin's clinical and research relevance stems from its selective action against eukaryotic fungal pathogens, notably Candida species, while exhibiting minimal activity against mammalian cells due to differences in membrane sterol composition (In-Depth Analysis). The compound enables mechanistic investigations into ergosterol-targeted disruption, antifungal resistance, and fungal adhesion in vitro and in vivo. It is not active against bacteria, viruses, or protozoa, underscoring its specificity (DOI).

    Mechanism of Action of Nystatin (Fungicidin)

    Nystatin exerts its antifungal effect by binding to ergosterol, a principal sterol in fungal cell membranes (APExBIO). This binding induces the formation of transmembrane pores, increasing membrane permeability and causing leakage of intracellular ions and molecules. The resultant loss of membrane integrity leads to cell lysis and death. Mammalian cells, which contain cholesterol instead of ergosterol, are less susceptible to this mechanism. Nystatin is classified as fungicidal, not fungistatic, in standard in vitro assays (Mechanisms and Model Systems). Notably, Nystatin does not inhibit clathrin-mediated endocytosis, as evidenced by its lack of effect on grass carp reovirus entry into CIK cells (Wang et al. 2018).

    Evidence & Benchmarks

    Applications, Limits & Misconceptions

    Nystatin (Fungicidin) is primarily used in the study of fungal adhesion, antifungal susceptibility, membrane disruption, and resistance mechanisms. It is a reference antifungal in the quality control of susceptibility testing. Researchers leverage its specificity to distinguish ergosterol-dependent processes from other cell membrane phenomena. APExBIO's Nystatin (Fungicidin) is widely adopted for these applications (product page). For a protocol-centric workflow and troubleshooting guidance, see this detailed guide—the present article extends these insights by providing updated, quantitative benchmarks and clarifying newly discovered boundaries of activity.

    Common Pitfalls or Misconceptions

    • Nystatin is ineffective against bacteria, viruses, and protozoa; its activity is limited to fungi containing ergosterol (Wang et al. 2018).
    • It does not inhibit clathrin-mediated endocytosis in mammalian or fish cell models (DOI).
    • Stock solutions degrade rapidly at room temperature or in aqueous media; long-term storage should be at or below -20°C, and working solutions used promptly (APExBIO).
    • Resistance in non-albicans Candida species may alter MIC values; always confirm with strain-specific testing (Mechanistic Innovations).
    • Nystatin is not suitable as a systemic therapeutic agent in humans due to poor absorption and toxicity profile; its primary use is in vitro and topical research (APExBIO).

    Workflow Integration & Parameters

    Nystatin (Fungicidin) (SKU B1993) from APExBIO is supplied as a solid with a molecular weight of 926.09 and chemical formula C47H75NO17 (APExBIO). Prepare stock solutions in DMSO at concentrations ≥30.45 mg/mL by gentle warming and ultrasonic shaking. The compound is insoluble in water and ethanol—do not attempt dissolution in these solvents. Store solid and stock solutions at -20°C. Avoid long-term storage of diluted (working) solutions; use promptly for maximal activity. For susceptibility testing, follow CLSI M27 and EUCAST protocols. For advanced workflow optimization, see this protocol article, which this review updates with new stability and activity data.

    For advanced insights into resistance mechanisms and model system selection, compare with this mechanistic review—the present article clarifies boundaries of Nystatin’s non-effect on viral endocytosis and updates molecular benchmark data.

    Conclusion & Outlook

    Nystatin (Fungicidin) remains a key experimental antifungal agent for research on Candida and other ergosterol-containing fungi. Its precise ergosterol-binding mechanism and reproducible in vitro activity make it indispensable for antifungal susceptibility and mechanistic studies (APExBIO). Recent research confirms its inactivity against viral entry pathways in aquatic models, refining our understanding of its boundaries (DOI). Standardized handling and storage protocols are critical for experimental fidelity. Ongoing research into resistance and formulation (e.g., liposomal Nystatin) will further extend its utility in translational mycology.